Use of Rituximab in Autoimmune Hemolytic Anemia Associated with Non-Hodgkin Lymphomas
The association between non-Hodgkin lymphomas and autoimmune disorders is a well-known event. Also autoimmune hemolytic anemia (AHA), although much more frequent in patients with chronic lymphocytic leukemia (CLL), has been described in this group of patients. In recent years, among the more tradi...
Saved in:
Main Authors: | Claudio Fozza, Maurizio Longinotti |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Advances in Hematology |
Online Access: | http://dx.doi.org/10.1155/2011/960137 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
T-Cell Traffic Jam in Hodgkin's Lymphoma: Pathogenetic and Therapeutic Implications
by: Claudio Fozza, et al.
Published: (2011-01-01) -
Autoimmune Hemolytic Anemia and Hodgkin’s Disease: An Unusual Pediatric Association
by: Maria Miguel Gomes, et al.
Published: (2016-01-01) -
Immunotherapy-associated autoimmune hemolytic anemia
by: Uqba Khan, et al.
Published: (2017-02-01) -
A Rare Association of Autoimmune Hemolytic Anemia with Gastric Adenocarcinoma
by: Kavita Agrawal, et al.
Published: (2017-01-01) -
Acute Brucellosis Presenting as an Autoimmune Hemolytic Anemia
by: Durga Shankar Meena, et al.
Published: (2018-01-01)